A detailed history of Lummis Asset Management, LP transactions in Johnson & Johnson stock. As of the latest transaction made, Lummis Asset Management, LP holds 6,255 shares of JNJ stock, worth $972,464. This represents 1.18% of its overall portfolio holdings.

Number of Shares
6,255
Previous 6,255 -0.0%
Holding current value
$972,464
Previous $914 Million 10.88%
% of portfolio
1.18%
Previous 1.21%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$144.38 - $157.78 $5,053 - $5,522
-35 Reduced 0.56%
6,255 $914 Million
Q1 2024

May 16, 2024

SELL
$155.22 - $162.74 $1.17 Million - $1.23 Million
-7,568 Reduced 54.61%
6,290 $995 Million
Q4 2023

Feb 14, 2024

BUY
$145.6 - $158.88 $2.02 Million - $2.2 Million
13,858 New
13,858 $2.17 Billion

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $406B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Lummis Asset Management, LP Portfolio

Follow Lummis Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lummis Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Lummis Asset Management, LP with notifications on news.